| dc.contributor.author | Andrews, PLR | en_US |
| dc.contributor.author | Golding, JFF | en_US |
| dc.contributor.author | Sanger, GJJ | en_US |
| dc.date.accessioned | 2023-07-21T10:22:24Z | |
| dc.date.available | 2023-07-04 | en_US |
| dc.date.issued | 2023 | en_US |
| dc.identifier.issn | 0306-5251 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/89721 | |
| dc.relation.ispartof | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | en_US |
| dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | |
| dc.subject | anti-cancer chemotherapy | en_US |
| dc.subject | gastroparesis | en_US |
| dc.subject | motion sickness | en_US |
| dc.subject | nausea | en_US |
| dc.subject | neurokinin(1) | en_US |
| dc.subject | substance P | en_US |
| dc.subject | vomiting | en_US |
| dc.title | An assessment of the effects of neurokinin(1) receptor antagonism against nausea and vomiting: Relative efficacy, sites of action and lessons for future drug development | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2023 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. | |
| dc.identifier.doi | 10.1111/bcp.15852 | en_US |
| pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:001049756000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
